Association between High-Sensitivity C-Reactive Protein and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Hepatitis C Virus Infection

被引:11
作者
Che, Wenliang [1 ]
Zhang, Buchun [1 ]
Liu, Wenling [2 ]
Wei, Yidong [1 ]
Xu, Yawei [1 ]
Hu, Dayi [2 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai 200072, Peoples R China
[2] Peking Univ, Peoples Hosp, Ctr Heart, Beijing 100044, Peoples R China
关键词
RISK; MYOCARDITIS; PREVENTION; DISEASE;
D O I
10.1155/2012/730923
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background. Prior study showed HCV-infected patients have increased serum N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) and a possible left ventricular diastolic dysfunction. The objectives of the present paper were to investigate the characteristics of hs-CRP and its correlation with clinical profiles including NT-proBNP and echocardiographic variables in HCV-infected patients. Methods and Results. A total of 106 HCV-infected patients and 106 control healthy individuals were enrolled. The level of serum hs-CRP (median 1.023 mg/L, range 0.03 similar to 5.379 mg/L) was significantly lower in all 106 patients than that in controls (median 3.147 mg/L, range 0.08 similar to 7.36 mg/L, P = 0.012). Although hs-CRP did not correlate significantly with NT-proBNP when all patients and controls were included (r = 0.169, P = 0.121), simple regression analysis demonstrated a statistically significant linear correlation between hs-CRP and NT-proBNP in HCV-infected patients group (r = 0.392, P = 0.017). Independent correlates of hs-CRP levels (R-2 = 0.13) were older age (beta' = 0.031, P = 0.025) and NT proBNP (beta' = 0.024, P = 0.017). Conclusions. Although the level of serum hs-CRP decreased significantly, there was a significant association between hs-CRP and NT-proBNP in HCV-infected patients.
引用
收藏
页数:6
相关论文
共 19 条
  • [1] High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C
    Antonelli, A.
    Ferri, C.
    Ferrari, S. M.
    Colaci, M.
    Sebastiani, M.
    Zignego, A. L.
    Ghiri, E.
    Goglia, F.
    Fallahi, P.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2010, 17 (12) : 851 - 853
  • [2] B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST segment elevation
    Bassan, R
    Potsch, A
    Maisel, A
    Tura, B
    Villacorta, H
    Nogueira, MV
    Campos, A
    Gamarski, R
    Masetto, AC
    Moutinho, MA
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (03) : 234 - 240
  • [3] Che W., J VIRAL HEP IN PRESS
  • [4] Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: A review
    Clerico, A
    Emdin, M
    [J]. CLINICAL CHEMISTRY, 2004, 50 (01) : 33 - 50
  • [5] Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men
    Floris-Moore, Michelle
    Howard, Andrea A.
    Lo, Yungtai
    Schoenbaum, Ellie E.
    Arnsten, Julia H.
    Klein, Robert S.
    [J]. AIDS PATIENT CARE AND STDS, 2007, 21 (07) : 479 - 491
  • [6] Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients
    Huang, Chung-Feng
    Hsieh, Ming-Yen
    Yang, Jeng-Fu
    Chen, Wu-Cheng
    Yeh, Ming-Lun
    Huang, Ching-I
    Dai, Chia-Yen
    Yu, Ming-Lung
    Lin, Zu-Yau
    Chen, Shinn-Chern
    Chuang, Wan-Long
    Huang, Jee-Fu
    [J]. HEPATOLOGY INTERNATIONAL, 2010, 4 (03) : 621 - 627
  • [7] Paradoxical alteration of acute-phase protein levels in patients with chronic hepatitis C treated with IFN-α2b
    Kalabay, L
    Nemesánszky, E
    Csepregi, A
    Pusztay, M
    Dávid, K
    Horváth, G
    Ibrányi, E
    Telegdy, L
    Pár, A
    Bíró, A
    Fekete, B
    Gervain, J
    Horányi, M
    Ribiczey, P
    Csöndes, M
    Kleiber, M
    Walentin, S
    Prohászka, Z
    Füst, G
    [J]. INTERNATIONAL IMMUNOLOGY, 2004, 16 (01) : 51 - 54
  • [8] C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
    Kaptoge, Stephen
    Di Angelantonio, Emanuele
    Lowe, Gordon
    Pepys, Mark B.
    Thompson, Simon G.
    Collins, Rory
    Danesh, John
    Tipping, R. W.
    Ford, C. E.
    Pressel, S. L.
    Walldius, G.
    Jungner, I.
    Folsom, A. R.
    Chambless, L.
    Ballantyne, C. M.
    Panagiotakos, D.
    Pitsavos, C.
    Chrysohoou, C.
    Stefanadis, C.
    Knuiman, M. W.
    Goldbourt, U.
    Benderly, M.
    Tanne, D.
    Whincup, P.
    Wannamethee, S. G.
    Morris, R. W.
    Kiechl, S.
    Willeit, J.
    Mayr, A.
    Schett, G.
    Wald, N.
    Ebrahim, S.
    Lawlor, D.
    Yarnell, J.
    Gallacher, J.
    Casiglia, E.
    Tikhonoff, V.
    Nietert, P. J.
    Sutherland, S. E.
    Bachman, D. L.
    Keil, J. E.
    Cushman, M.
    Psaty, B. M.
    Tracy, R.
    Tybjaerg-Hansen, A.
    Nordestgaard, B. G.
    Zacho, J.
    Frikke-Schmidt, R.
    Giampaoli, S.
    Palmieri, L.
    [J]. LANCET, 2010, 375 (9709) : 132 - 140
  • [9] Myocarditis and heart failure associated with hepatitis C virus infection
    Matsumori, A
    Shimada, T
    Chapman, NM
    Tracy, SM
    Mason, JW
    [J]. JOURNAL OF CARDIAC FAILURE, 2006, 12 (04) : 293 - 298
  • [10] Hepatitis C virus infection and cardiomyopathies
    Matsumori, A
    [J]. CIRCULATION RESEARCH, 2005, 96 (02) : 144 - 147